Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia

This publication has 18 references indexed in Scilit:

• From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
  The Journal of Infectious Diseases, 1990
• Therapy of small cell lung cancer: Anything new?
  European Journal of Cancer and Clinical Oncology, 1988
• What is the Cost of Nephrotoxicity Associated with Aminoglycosides?
  Annals of Internal Medicine, 1987
• Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy
  The American Journal of Medicine, 1987
• Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients
  Antimicrobial Agents and Chemotherapy, 1987
• Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections
  Antimicrobial Agents and Chemotherapy, 1987
• Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia
  The American Journal of Medicine, 1986
• Randomized comparison between two ceftazidime-containing regimens and cephalothin-gentamicin-carbenicillin in febrile granulocytopenic cancer patients
  Antimicrobial Agents and Chemotherapy, 1986
• Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria
  Antimicrobial Agents and Chemotherapy, 1986
• Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients
  Antimicrobial Agents and Chemotherapy, 1984